MA53553A - Traitement post-chirurgical de la douleur - Google Patents

Traitement post-chirurgical de la douleur

Info

Publication number
MA53553A
MA53553A MA053553A MA53553A MA53553A MA 53553 A MA53553 A MA 53553A MA 053553 A MA053553 A MA 053553A MA 53553 A MA53553 A MA 53553A MA 53553 A MA53553 A MA 53553A
Authority
MA
Morocco
Prior art keywords
surgical pain
pain treatment
post surgical
post
treatment
Prior art date
Application number
MA053553A
Other languages
English (en)
French (fr)
Inventor
Thomas B Ottoboni
Barry D Quart
Original Assignee
Heron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heron Therapeutics Inc filed Critical Heron Therapeutics Inc
Publication of MA53553A publication Critical patent/MA53553A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA053553A 2018-09-07 2019-09-06 Traitement post-chirurgical de la douleur MA53553A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862728732P 2018-09-07 2018-09-07
US201962860190P 2019-06-11 2019-06-11

Publications (1)

Publication Number Publication Date
MA53553A true MA53553A (fr) 2021-07-14

Family

ID=68138775

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053553A MA53553A (fr) 2018-09-07 2019-09-06 Traitement post-chirurgical de la douleur

Country Status (12)

Country Link
US (1) US20200078363A1 (enExample)
EP (1) EP3846811B1 (enExample)
JP (2) JP2021536477A (enExample)
KR (1) KR20210060492A (enExample)
CN (1) CN112955144A (enExample)
AU (1) AU2019337104B2 (enExample)
BR (1) BR112021004331A2 (enExample)
CA (1) CA3111570A1 (enExample)
MA (1) MA53553A (enExample)
MX (1) MX2021002556A (enExample)
TW (1) TW202023567A (enExample)
WO (1) WO2020051543A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992485B2 (en) * 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11559521B2 (en) * 2013-07-22 2023-01-24 William Bradley Worthington Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992484B2 (en) * 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
JP2021512091A (ja) * 2018-01-30 2021-05-13 ヘロン セラピューティクス, インコーポレイテッドHeron Therapeutics, Inc. Nk−1受容体アンタゴニストのエマルジョン製剤の投与方法
CN115515581A (zh) * 2020-01-10 2022-12-23 帕西拉制药股份有限公司 通过给予缓释脂质体麻醉组合物治疗疼痛
CA3205758A1 (en) * 2021-01-29 2022-08-04 William Taylor Compositions and methods for sustained treatment of pain
WO2023154293A1 (en) * 2022-02-08 2023-08-17 Saint Cyr Michael Hector Anesthetic formulations and methods
CN116898977B (zh) * 2022-07-20 2025-07-15 四川大学华西医院 一种麻醉镇痛的联合用药物
CN116041342B (zh) * 2022-12-30 2024-02-20 加立(深圳)生物科技有限公司 罗哌卡因/美洛昔康盐的一水合物i晶型、药物组合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508961A (ja) * 2002-11-12 2006-03-16 オメロス コーポレイション 腫瘍細胞接着、疼痛、および炎症を阻害するための灌注溶液および方法
EP2021005A4 (en) * 2006-05-03 2009-11-25 Cnsbio Pty Ltd METHOD AND COMPOSITION FOR THE TREATMENT OF INFLAMMATORY PAIN
US20100316678A1 (en) * 2007-06-28 2010-12-16 Cnsbio Pty Ltd. Combination methods and compositions for treatment of neuropathic pain
US8992951B2 (en) * 2013-01-09 2015-03-31 Sapna Life Sciences Corporation Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
US9744163B2 (en) * 2013-03-15 2017-08-29 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
CA3174824A1 (en) * 2014-04-21 2015-10-29 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
US9801945B2 (en) * 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
US11083730B2 (en) * 2014-04-21 2021-08-10 Heron Therapeutics, Inc. Long-acting polymeric delivery systems

Also Published As

Publication number Publication date
CA3111570A1 (en) 2020-03-12
EP3846811A1 (en) 2021-07-14
JP2021536477A (ja) 2021-12-27
AU2019337104A1 (en) 2021-03-25
BR112021004331A2 (pt) 2021-08-03
MX2021002556A (es) 2021-06-15
US20200078363A1 (en) 2020-03-12
TW202023567A (zh) 2020-07-01
AU2019337104B2 (en) 2025-05-15
EP3846811C0 (en) 2025-11-05
WO2020051543A1 (en) 2020-03-12
CN112955144A (zh) 2021-06-11
EP3846811B1 (en) 2025-11-05
JP2025010592A (ja) 2025-01-22
KR20210060492A (ko) 2021-05-26

Similar Documents

Publication Publication Date Title
EP3813647A4 (en) MULTIMODAL STIMULATION FOR TREMOR TREATMENT
EP3813808A4 (en) Methods of treating substance abuse
EP4072456A4 (en) TISSUE MAPPING AND TREATMENT
KR102199943B9 (ko) 의료용 자극 장치
EP3397149A4 (en) TISSUE CHARTING AND TREATMENT
EP3448263A4 (en) ELECTROTHERAPEUTIC TREATMENT
EP3648841A4 (en) TREATMENT OF INTERNAL ORGANS, INJURY AND PAIN
EP3351188A4 (en) ENDOSCOPE TREATMENT INSTRUMENT
EP3351186A4 (en) ENDOSCOPE TREATMENT INSTRUMENT
PT3773558T (pt) Tratamento combinado de doença artrítica
EP4076217A4 (en) SYNDESMOSIS TREATMENT CONSTRUCT
EP3946345A4 (en) METHODS OF TREATMENT OF NEUROPATHIC PAIN
EP3669791A4 (en) MEDICAL PLIERS
EP3862000A4 (en) MEDICATIONS FOR THE TREATMENT OF CHRONIC COUGH
EP3458062A4 (en) Treatment of pain
IL280638A (en) Fat tissue treatment
MA49440A (fr) Elément de cicatrisation dentaire
EP3592377A4 (en) DOSAGE FORMS OF TISSUE KALLIKREIN 1
EP3773539A4 (en) COMPOSITIONS FOR THE TREATMENT OF THE SKIN
EP3873528A4 (en) Rasopathy treatment
EP4069438A4 (en) SKIN TREATMENT SYSTEM
EP3960924C0 (en) CLOTHING TREATMENT DEVICE
EP3856207A4 (en) TREATMENT PROCESSES
EP4405465A4 (en) TREATMENT METHODS
EP3773448C0 (en) HAIR TREATMENT PROCESS